References

1. Testa, B.; Jenner, P. Drug Metab. Rev. 1978, 7, 325-369.

3. Testa, B. The Metabolism of Drugs and Other Xenobiotics-Biochemistry of Redox Reactions; Academic Press: London, UK, 1995.

4. Testa, B.; Soine, W In Burger's Medicinal Chemistry and Drug Discovery, 6th ed.; Abraham, D. J., Ed.; Wiley-Interscience: Hoboken, NJ, 2003; Vol. 2, pp 431-498.

5. Testa, B.; Mayer, J. M. Hydrolysis in DrugandProdrug Metabolism - Chemistry, Biochemistry andEnzymology; Wiley-Verlag Helvetica Chimica Acta: Zurich, Switzerland, 2003.

6. www.chem.qmul.ac.uk/iubmb/enzyme/ (accessed May 2006).

7. www.biochem.ucl.ac.uk/bsm/enzymes/ (accessed May 2006).

8. Satoh, T; Hosokawa, M. Annu. Rev. Pharmacol. Toxicol. 1998, 38, 257-288.

9. Satoh, T; Taylor, P.; Bosron, W F; Sanghani, S. P.; Hosokawa, M.; La Du, B. N. Drug Metab. Dispos. 2002, 30, 488-493.

10. Teiber, J. F; Draganov, D. I.; La Du, B. N. Biochem. Pharmacol. 2003, 66, 887-896.

11. Costa, L. G.; Vitalone, A.; Cole, T. B.; Furlong, C. E. Biochem. Pharmacol. 2005, 69, 541-550.

12. Dodson, G.; Wlodawer, A. Trends Biol. Sci. 1998, 23, 347-352.

13. Roberts, S. M.; Phillips, D. L.; Tebbett, I. R. Drug Metab. Dispos. 1995, 23, 664-666.

14. Laizure, S. C.; Mandrell, T.; Gades, N. M.; Parker, R. B. Drug Metab. Dispos. 2003, 31, 16-20.

15. Parker, R. J.; Collins, J. M.; Strong, J. M. Drug Metab. Dispos. 1996, 24, 1167-1173.

16. Alexson, S. E. H.; Diczfalusy, M.; Halldin, M.; Swedmark, S. Drug Metab. Dispos. 2002, 30, 643-647.

17. Strolin-Benedetti, M.; Whomsley, R.; Nicolas, J. M.; Young, C.; Baltes, E. Eur. J. Clin. Pharmacol. 2003, 59, 621-630.

18. Reist, M.; Carrupt, P A.; Francotte, E.; Testa, B. Chem. Res. Toxicol. 1998, 11, 1521-1528.

19. Schumacher, H.; Smith, R. L.; Williams, R. T Br. J. Pharmacol. 1965, 25, 338-351.

20. Chen, T L.; Vogelsang, G. B.; Petty, B. G.; Brundrett, R. B.; Noe, D. A.; Santos, G. W; Colvin, O. M. Drug Metab. Dispos. 1989, 17, 402-405.

21. Lu, J.; Helsby, N.; Palmer, B. D.; Tingle, M.; Baguley, B. C.; Kestell, P; Ching, L. M. J. Pharmacol. Exp. Therap. 2004, 310, 571-577.

22. Barrett, A. J.; Rawlings, N. D.; Woessner, J. F; Eds.; Handbook of Proteolytic Enzymes, 2nd ed.; Elsevier: Oxford, UK, 2004, 2 volumes.

23. Naruki, M.; Mizutani, S.; Goto, K.; Tsujimoto, M.; Nakazato, H.; Itakura, A.; Mizuno, M.; Kurauchi, O.; Kikkawa, F; Tomoda, Y Peptides 1996, 17, 257-261.

24. Mitchell, B. F.; Wong, S. J. Clin. Endocrinal. Metab. 1995, 80, 2729-2733.

25. Schwahn, M.; Schupke, H.; Gasparic, A.; Krone, D.; Peter, G.; Hempel, R.; Kronbach, T; Locher, M.; Jahn, W; Engel, J. Drug Metab. Dispos. 2000, 28, 10-20.

26. Armstrong, R. N. Drug Metab. Rev. 1999, 31, 71-86.

27. Armstrong, R. N.; Cassidy, C. S. Drug Metab. Rev. 2000, 32, 327-338.

28. Seidegard, J.; DePierre, J. W Biochim. Biophys. Acta 1983, 695, 251-270.

29. Halpin, R. A.; Geer, L. A.; Zhang, K. E.; Marks, T. M.; Dean, D. C.; Jones, A. N.; Melillo, D.; Doss, G.; Vyas, K. P. Drug Metab. Dispos. 2000, 28, 1244-1254.

30. Slack, J. A.; Ford-Hutchinson, A. W; Richold, M.; Choi, B. C. K. Chem.-Biol. Interact. 1981, 34, 95-107.

31. Harvey, D. J.; Glazener, L.; Johnson, D. B.; Butler, C. M.; Horning, M. G. Drug Metab. Dispos. 1977, 5, 527-546.

32. Watabe, T.; Hiratsuka, A.; Ozawa, N.; Isobe, M. Xenobiotica 1981, 11, 333-344.

33. Svinarov, D. A.; Pippenger, C. E. Ther. Drug Monit. 1996, 18, 660-665.

34. Green, V J.; Pirmohamed, M.; Kitteringham, N. R.; Gaedigk, A.; Grant, D. M.; Boxer, M.; Burchell, B.; Park, B. K. Biochem. Pharmacol. 1995, 50, 1353-1359.

35. Kitteringham, N. R.; Davis, C.; Howard, N.; Pirmohamed, M.; Park, B. K. J. Pharmacol. Exp. Ther. 1996, 278, 1018-1027.

36. Testa, B.; Jenner, P. Drug Metabolism. Chemical and Biochemical Aspects; Marcel Dekker: New York, 1976.

37. Mulder, G. J., Ed. Conjugation Reactions in Drug Metabolism; Taylor & Francis: London, UK, 1990.

38. Kauffman, F C., Ed. Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity; Springer Verlag: Berlin, Germany, 1994.

39. Woolf, T F, Ed. Handbook of Drug Metabolism; Marcel Dekker: New York, 1999.

40. Ioannides, C., Ed. Enzyme Systems that Metabolise Drugs and Other Xenobiotics; John Wiley & Sons: Chichester, UK, 2002.

41. Fujioka, M. Int. J. Biochem. 1992, 24, 1917-1924.

42. Weinshilboum, R. M.; Otterness, D. M.; Szumlanski, C. L. Annu. Rev. Pharmacol. Toxicol. 1999, 39, 19-52.

43. Weinshilboum, R. M. Pharm. News 2000, 7, 19-25.

44. Faigle, J. W; Böttcher, I.; Godbillon, J.; Kriemler, H. P.; Schlumpf, E.; Schneider, W; Schweizer, A.; Stierlin, H.; Winkler, T Xenobiotica 1988, 18, 1191-1197.

45. Lautala, P; Ulmanen, I.; Taskinen, J. Mol. Pharmacol. 2001, 59, 393-402.

46. Taskinen, J.; Ethell, B. T; Puhlavisto, P; Hood, A. M.; Burchell, B.; Coughtrie, M. W H. Drug Metab. Dispos. 2003, 31, 1187-1197.

47. Iyer, R. A.; Malhotra, B.; Khan, S.; Mitroka, J.; Bonacorsi, S., Jr.; Waller, S. C.; Rinehart, J. K.; Kripalani, K. Drug Metab. Dispos. 2003, 31, 67-75.

48. Bahnmaier, A. H.; Woesle, B.; Thomas, H. Chirality 1999, 11, 160-165.

49. Crooks, P A.; Godin, C. S.; Damani, L. A.; Ansher, S. S.; Jakoby, W B. Biochem. Pharmacol. 1988, 37, 1673-1677.

50. Armstrong, J. I.; Bertozzi, C. R. Curr. Opin. Drug Disc. Dev. 2000, 3, 502-515.

51. Raftogianis, R. B.; Wood, T. C.; Weinshilboum, R. M. Biochem. Pharmacol. 1999, 58, 605-616.

53. Nagata, K.; Yamazoe, Y Annu. Rev. Pharmacol. Toxicol. 2000, 40, 159-176.

54. Coughtrie, M. W H.; Johnston, L. E. Drug Metab. Dispos. 2001, 29, 522-528.

55. Glatt, H.; Boeing, H.; Engelke, C. E. H.; Ma, L.; Kuhlow, A.; Pabel, U.; Pomplun, D.; Teubner, W; Meinl, W Mutat. Res. 2001, 482, 27-40.

56. Tabrett, C. A.; Coughtrie, M. W H. Biochem. Pharmacol. 2003, 66, 2089-2097.

57. Kauffman, F, C. Drug Metab. Rev. 2004, 36, 823-843.

58. Chen, G. Biochem. Pharmacol. 2004, 67, 1355-1361.

59. Tsoi, C.; Swedmark, S. Curr. Drug Metab. 2005, 6, 275-285.

60. Runge-Morris, M.; Kocarek, T. A. Curr. Drug Metab. 2005, 6, 299-307.

61. Yamazaki, H.; Shibata, A.; Suzuki, M.; Nakajima, M.; Shimada, N.; Guengerich, F P.; Yokoi, T Drug Metab. Dispos. 1999, 27, 1260-1266.

62. Miyano, J.; Yamamoto, S.; Hanioka, N.; Narimatsu, S.; Ishikawa, T.; Ogura, K.; Watabe, T.; Nishimura, M.; Ueda, N.; Naito, S. Biochem. Pharmacol. 2005, 69, 941-950.

63. Tsai, R. S.; Carrupt, P. A.; Testa, B.; Caldwell, J. Chem. Res. Toxicol. 1994, 7, 73-76.

64. Dasaradhi, L.; Shibutani, S. Chem. Res. Toxicol. 1997, 10, 189-196.

65. Meisheri, K. D.; Johnson, G. A.; Puddington, L. Biochem. Pharmacol. 1993 , 45, 271-279.

66. Shiraga, T; Hata, T; Yamazoe, Y; Ohno, Y; Iwasaki, K. Xenobiotica 1999, 29, 341-347.

67. Dalvie, D. K.; Khosla, N.; Vincent, J. Drug Metab. Dispos. 1997, 25, 423-427.

68. Zhu, C.; Johansson, M.; Permert, J.; Karlsson, A. Biochem. Pharmacol. 1998, 56, 1035-1040.

69. Feng, J. Y; Parker, W B.; Krajewski, M. L.; Deville-Bonne, D.; Veron, M.; Krishnan, P; Cheng, Y C.; Borroto-Esoda, K. Biochem. Pharmacol. 2004, 68, 1879-1888.

70. Peters, K.; Gambertoglio, J. G. Clin. Pharmacol. Therap. 1996, 60, 168-176.

71. Albert, R.; Hinterding, K.; Brinkmann, V.; Guerini, D.; Muöller-Hartwieg, C.; Knecht, H.; Simeon, C.; Streiff, M.; Wagner, T.; Welzenbach, K. et al. J. Med. Chem. 2005, 48, 5373-5377.

72. som.flinders.edu.au/FUSA/ClinPharm/UGT (accessed May 2006).

73. Radominska-Pandya, A.; Czernik, P J.; Little, J. M.; Battaglia, E.; Mackenzie, P. I. Drug Metab. Rev. 1999, 31, 817-899.

74. Tukey, R. H.; Strassburg, C. P Annu. Rev Pharmacol. Toxicol. 2000, 40, 581-616.

75. Fisher, M. B.; Paine, M. F; Strelevitz, T J.; Wrighton, S. A. Drug Metab. Rev. 2001, 33, 273-297.

76. Bock, K. W Biochem. Pharmacol. 2003 , 66, 691-696.

77. Wells, P; Mackenzie, P I.; Roy, J.; Guillemette, C.; Gregory, P A.; Ishii, Y; Hansen, A. J.; Kessler, F K.; Kim, P M.; Chowdhury, N. R.; Ritter, J. K. Drug Metab. Dispos. 2004, 32, 281-290.

78. Maruo, Y; Iwai, M.; Mori, A.; Sato, H.; Takeuchi, Y Curr. Drug Metab. 2005, 6, 91-99.

79. Kessler, F K.; Kessler, M. R.; Auyeung, D. J.; Ritter, J. K. Drug Metab. Dispos. 2002, 30, 324-330.

80. Court, M. H.; Duan, S. X.; Guillemette, C.; Journault, K.; Krishnaswamy, S.; von Moltke, L. L.; Greenblatt, D. J. Drug Metab. Dispos. 2002, 30, 1257-1265.

81. Barbier, O.; Turgeon, D.; Girard, C.; Green, M. D.; Tephly, T R.; Hum, D. W; Belanger, A. Drug Metab. Dispos. 2000, 28, 497-502.

82. Milne, R. W; Nation, R. L.; Somogyi, A. A. Drug Metab. Rev. 1996, 28, 345-472.

83. Miller, R. R.; Doss, G. A.; Stearns, R. A. Drug Metab. Dispos. 2004, 32, 178-185.

84. Spahn-Langguth, H.; Benet, L. Z. Drug Metab. Rev. 1992, 24, 5-48.

85. Skordi, E.; Wilson, I. D.; Lindon, J. C.; Nicholson, J. K. Xenobiotica 2005, 35, 715-725.

86. Green, M. D.; Tephly, T R. Drug Metab. Dispos. 1998, 26, 860-867.

87. Kaivosaari, S.; Salonen, J. S.; Taskinen, J. Drug Metab. Dispos. 2002, 30, 295-300.

88. Lee Chiu, S. H.; Huskey, S. W Drug Metab. Dispos. 1998, 26, 838-847.

89. Hawes, E. M. Drug Metab. Dispos. 1998, 26, 830-837.

90. Smith, P. A.; Sorich, M. J.; McKinnon, R. A.; Miners, J. O. J. Med. Chem. 2003, 46, 1617-1626.

91. Sorich, M. J.; Miners, J. O.; McKinnon, R. A.; Smith, P. A. Mol. Pharmacol. 2004, 65, 301-308.

92. Grant, D. M.; Blum, M.; Meyer, U. A. Xenobiotica 1992, 22, 1073-1081.

93. Agundez, J. A. G.; Olivera, M.; Martinez, C.; Ladero, J. M.; Benitez, J. Pharmacogenetics 1996, 6, 423-428.

94. Kawamura, A.; Graham, J.; Mushtaq, A.; Tsiftsoglou, S. A.; Vath, G. M.; Hanna, P. E.; Wagner, C. R.; Sim, E. Biochem. Pharmacol. 2005, 69, 347-359.

95. Mattano, S. S.; Land, S.; King, C. M.; Weber, W W Mol. Pharmacol. 1989, 35, 599-609.

96. Bhat, H. K.; Ansari, G. A. S. Chem. Res. Toxicol. 1990, 3, 311-317.

97. Knights, K. M.; Drogemuller, C. J. Curr. Drug Metab. 2000, 1, 49-66.

98. Kasuya, F; Igarashi, K.; Fukui, M. Biochem. Pharmacol. 1996, SI, 805-809.

99. Brugger, R.; Reichel, C.; Garcia Alia, B.; Brune, K.; Yamamoto, T; Tegeder, I.; Geissinger, G. Biochem. Pharmacol. 2001, 61, 651-656.

100. Mayer, J. M.; Roy-de Vos, M.; Audergon, C.; Testa, B. Arch. Toxicol. 1995, S17, 499-513.

101. Kanazu, T; Yamaguchi, T Drug Metab. Dispos. 1997, 2S, 149-153.

102. Kasumov, T; Brunengraber, L. L.; Comze, C.; Puchowicz, M. A.; Jobbins, K.; Thomas, K.; David, F; Kinman, R.; Wehrli, S.; Dahms, W et al. Drug Metab Dispos. 2004, 32, 10-19.

103. Gopaul, V S.; Tang, W; Farrell, K.; Abbott, F S. Drug Metab. Dispos. 2003, 31, 114-121.

104. Mohri, K.; Okada, K.; Benet, L. Z. Pharm. Res. 2005, 22, 79-85.

105. Kim, M. S.; Shen, Z.; Kochansky, C.; Lynn, K.; Wang, S.; Wang, Z.; Hora, D.; Brunner, J.; Franklin, R . B.; Vincent, S. H. Xenobiotica 2004, 34, 665-674.

107. Vickery, S.; Dodds, P F Xenobiotica 2004, 34, 1025-1042.

108. Sun, E. L.; Feenstra, K. L.; Bell, F P; Sanders, P E.; Slatter, J. G.; Ulrich, R. G. Drug Metab. Dispos. 1996, 24, 221-231.

109. Siafaka-Kapadai, A.; Patiris, M.; Bowden, C.; Javors, M. Biochem. Pharmacol. 1998, S6, 207-212.

110. Bjorge, S. M.; Baillie, T A. Drug Metab. Dispos 1991, 19, 823-829.

111. Hulsman, J. Pharm. Weekbl. Sci. Ed. 1992, 14, 98-100.

112. Reed, D. J. Annu. Rev. Pharmacol. Toxicol. 1990, 30, 603-631.

113. Sies, H. Free Rad. Biol. Med. 1999, 27, 916-921.

114. Dickinson, D. A.; Forman, H. J. Biochem. Pharmacol. 2002, 64, 1019-1026.

115. Pompella, A.; Visvikis, A.; Paolicchi, A.; De Tala, V; Casini, A. F Biochem. Pharmacol. 2003, 66, 1499-1503.

116. Ross, D. Pharmacol. Therap. 1988, 37, 231-249.

117. Hayes, J. D.; Pullford, D. J. Crit. Rev Biochem. Mol. Biol. 1995, 30, 445-600.

118. Armstrong, R. N. Chem. Res. Toxicol. 1997, 10, 2-18.

119. Sheenan, D.; Meade, G.; Foley, V M.; Dowd, C. Biochem. J. 2001, 360, 1-16.

120. Jowsey, I. R.; Thomson, A. M.; Flanagan, J. U.; Murdock, P R.; Moore, G. B. T; Meyer, D. J.; Murphy, G. J.; Smith, S. A.; Hayes, J. D. Biochem. J. 2001, 3S9, 507-516.

121. Schnekenburger, M.; Morceau, F; Duvoix, A.; Delhalle, S.; Trentesaux, C.; Dicato, M.; Diederich, M. Biochem. Pharmacol. 2004, 68, 1269-1277.

122. Winayanuwattikun, P; Ketterman, A. J. Biochem. J. 2004, 382, 751-757.

123. Robinson, A.; Huttley, G. A.; Booth, H. S.; Board, P G. Biochem. J. 2004, 379, 541-552.

124. Ketterer, B. Drug Metab. Rev. 1982, 13, 161-187.

126. Monks, T. J.; Lau, S. S. Chem. Res. Toxicol. 1997, 10, 1296-1313.

127. Baillie, T A.; Slatter, J. G. Acc. Chem. Res. 1991, 24, 264-270.

128. Zjang, J. Y; Yuan, J. J.; Wang, Y F; Bible, R. H., Jr.; Breau, A. P. Drug Metab. Dispos. 2003, 31, 491-501.

129. Dirven, H. A. A. M.; van Ommen, B.; van Bladeren, P. J. Chem. Res. Toxicol. 1996, 9, 351-360.

130. Grillo, M. P; Hua, F Drug Metab. Dispos. 2003, 31, 1429-1436.

131. Anders, M. W; Dekant, W Annu. Rev Pharmacol. Toxicol. 1998, 38, 501-537.

132. Anders, M. W Drug Metab. Rev 2004, 36, 583-594.

Bernard Testa studied pharmacy because he was unable to choose between medicine and chemistry. Because he was incapable of working in a community pharmacy, he undertook a PhD thesis on the physicochemistry of drug-macromolecule interactions. Because he felt himself ungifted for the pharmaceutical industry, he went for 2 years to Chelsea College, University of London, for postdoctoral research under the supervision of Prof Arnold H Beckett. And because these were easy times, he was called as assistant professor to the University of Lausanne, Switzerland, to become full professor and Head of Medicinal Chemistry in 1978. Since then, he has tried to repay his debts by fulfilling

Biography

a number of local and international commitments, e.g., Dean of the Faculty of Sciences (1984-86), Director of the Geneva-Lausanne School of Pharmacy (1994-96 and 1999-2001), and President of the University Senate (1998-2000). He has written four books and edited 29 others, and (co)-authored 450 research and review articles in the fields of drug design and drug metabolism. During the years 1994-98, he was the Editor-Europe of Pharmaceutical Research, the flagship journal of the American Association of Pharmaceutical Scientists (AAPS), and he is now the co-editor of the new journal Chemistry and Biodiversity. He is also a member of the Editorial Board of several leading journals (e.g., Biochemical Pharmacology, Chirality, Drug Metabolism Reviews, Helvetica Chimica Acta, Journal of Pharmacy and Pharmacology, Medicinal Research Reviews, Pharmaceutical Research, Xenobiotica). He holds honorary doctorates from the universities of Milan, Montpellier, and Parma, and was the 2002 recipient of the Nauta Award on Pharmacochemistry given by the European Federation for Medicinal Chemistry. He was elected a Fellow of the AAPS, and is a member of a number of scientific societies such as the French Academy of Pharmacy, the Royal Academy of Medicine of Belgium, and the American Chemical Society. His recently granted Emeritus status has freed him from administrative duties and gives him more time for writing, editing, and collaborating in research projects. His hobbies, interests, and passions include jogging, science-fiction, epistemology, teaching, and scientific exploration.

© 2007 Elsevier Ltd. All Rights Reserved Comprehensive Medicinal Chemistry II

No part of this publication may be reproduced, stored in any retrieval system or transmitted ISBN (set): 0-08-044513-6 in any form by any means electronic, electrostatic, magnetic tape, mechanical, photocopying, recording or otherwise, without permission in writing from the publishers ISBN (Volume 5) 0-08-044518-7; pp. 133-166

Was this article helpful?

0 0
Lower Your Cholesterol In Just 33 Days

Lower Your Cholesterol In Just 33 Days

Discover secrets, myths, truths, lies and strategies for dealing effectively with cholesterol, now and forever! Uncover techniques, remedies and alternative for lowering your cholesterol quickly and significantly in just ONE MONTH! Find insights into the screenings, meanings and numbers involved in lowering cholesterol and the implications, consideration it has for your lifestyle and future!

Get My Free Ebook


Post a comment